Hepatitis A vaccines (Q34787404)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Hepatitis A vaccines	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

1 reference

Europe PubMed Central

Hepatitis A vaccines. (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

1 reference

based on heuristic

inferred from title

author name string

Hans Dieter Nothdurft

1

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

publication date

1 July 2008

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Expert Review of Vaccines

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

535-545

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Hepatitis A in the era of vaccination

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.535

21 January 2018

Combined hepatitis A and B vaccines: a review of their immunogenicity and tolerability

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.535

21 January 2018

Prevention of hepatitis A by Havrix: a review

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.535

21 January 2018

The cost of hepatitis A infections in American adolescents and adults in 1997.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.535

21 January 2018

Hepatitis A virus infections in travelers, 1988-2004.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.535

21 January 2018

Epidemiology and prevention of hepatitis A in travelers

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.535

21 January 2018

The risk of acquiring hepatitis A and B among travelers in selected Eastern and Southern Europe and non-European Mediterranean countries: review and consensus statement on hepatitis A and B vaccination.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.535

21 January 2018

Hepatitis A and B infection and vaccination in a cohort of homosexual men in Sydney

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.535

21 January 2018

Multiple modes of hepatitis A virus transmission among methamphetamine users.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.535

21 January 2018

An outbreak of hepatitis A virus infection with a high case-fatality rate among injecting drug users

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.535

21 January 2018

Outbreak of hepatitis A in the injecting drug user and homeless populations in Bristol: control by a targeted vaccination programme and possible parenteral transmission

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.535

21 January 2018

An outbreak of hepatitis A among homeless drug users in Rotterdam, The Netherlands

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.535

21 January 2018

Hepatitis and human immunodeficiency virus co-infection among injection drug users in Los Angeles County, California

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.535

21 January 2018

The role of child care in a community-wide outbreak of hepatitis A.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.535

21 January 2018

Cost-effectiveness of childhood hepatitis A vaccination in Argentina: a second dose is warranted

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.535

21 January 2018

Epidemiological pattern and mortality rates for hepatitis A in Brazil, 1980-2002--a review

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.535

21 January 2018

Hepatitis A shifting epidemiology in South-East Asia and China

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.535

21 January 2018

A review of licensed viral vaccines, some of their safety concerns, and the advances in the development of investigational viral vaccines

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.535

21 January 2018

Hepatitis A vaccine in the last-minute traveler

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.535

21 January 2018

The underestimated risk of hepatitis A and hepatitis B: benefits of an accelerated vaccination schedule

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.535

21 January 2018

Hepatitis A vaccine versus immune globulin for postexposure prophylaxis

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.535

21 January 2018

Production, quality control and characterization of an inactivated hepatitis A vaccine

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.535

21 January 2018

Development of the formalin-inactivated hepatitis A vaccine, VAQTA from the live attenuated virus strain CR326F.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.535

21 January 2018

Safety and immunogenicity of a new formulation of an inactivated hepatitis A vaccine.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.535

21 January 2018

Immunogenicity of an inactivated hepatitis A pediatric vaccine: three-year post-booster follow-up.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.535

21 January 2018

Immunogenicity and protectivity of a new liposomal hepatitis A vaccine

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.535

21 January 2018

Rapid antibody response after vaccination with a virosomal hepatitis a vaccine.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.535

21 January 2018

Development of live, attenuated hepatitis A vaccine (H2-strain).

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.535

21 January 2018

A review of the efficacy, immunogenicity and tolerability of a combined hepatitis A and B vaccine

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.535

21 January 2018

Combined typhoid fever and hepatitis A vaccine: comparison of immunogenicity and safety to concomitant monovalent vaccine over 3 years

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.535

21 January 2018

Incidence of hepatitis A in Israel following universal immunization of toddlers

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.535

21 January 2018

Hepatitis A and B vaccination and public health

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.535

21 January 2018

Immunogenicity of an inactivated hepatitis A vaccine in infants and young children

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.535

21 January 2018

Safety, immunogenicity and antibody persistence of an inactivated hepatitis A vaccine in 4 to 15 year old children

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.535

21 January 2018

Excellent booster response 4 to 8 years after a single primary dose of an inactivated hepatitis A vaccine

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.535

21 January 2018

Hepatitis A vaccine: immunogenicity following administration of a delayed immunization schedule in infants, children and adults.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.535

21 January 2018

Successful Booster Antibody Response up to 54 Months after Single Primary Vaccination with Virosome-Formulated, Aluminum-Free Hepatitis A Vaccine

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.535

21 January 2018

Immunogenicity of booster vaccination with a virosomal hepatitis A vaccine after primary immunization with an aluminum-adsorbed hepatitis A vaccine

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.535

21 January 2018

Immunogenicity and safety of two doses of a paediatric hepatitis A vaccine in thai children: comparison of three vaccination schedules

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.535

21 January 2018

A review of the long-term protection after hepatitis A and B vaccination

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.535

21 January 2018

Hepatitis A vaccine: indirect evidence of immune memory 12 years after the primary course.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.535

21 January 2018

Long-term immunogenicity of an inactivated virosome hepatitis A vaccine.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.535

21 January 2018

Hepatitis A booster vaccination: is there a need?

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.535

21 January 2018

Hepatitis A virus-specific humoral and cellular immune responses following immunization with a formalin-inactivated hepatitis A vaccine

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.535

21 January 2018

Do we need hepatitis A booster vaccinations?

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.535

21 January 2018

Effect of maternal antibody on immunogenicity of hepatitis A vaccine in infants

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.535

21 January 2018

Antibody titres after primary and booster vaccination of infants and young children with a virosomal hepatitis A vaccine (Epaxal®)

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.535

21 January 2018

Safety and Immunogenicity of Hepatitis A Vaccine in Human Immunodeficiency Virus–Infected Patients: A Double‐Blind, Randomized, Placebo‐Controlled Trial

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.535

21 January 2018

Safety and immunogenicity of an inactivated hepatitis A vaccine among HIV-infected subjects

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.535

21 January 2018

Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.535

21 January 2018

The effect of age and weight on the response to formalin inactivated, alum-adjuvanted hepatitis A vaccine in healthy adults

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.535

21 January 2018

Cost-effectiveness of universal childhood hepatitis A vaccination in Chile

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.535

21 January 2018

Outbreak of Hepatitis A among Men Who Have Sex with Men: Implications for Hepatitis A Vaccination Strategies

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.535

21 January 2018

Rapid protection and vaccination against hepatitis A for travellers

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.535

21 January 2018

Identifiers

10.1586/14760584.7.5.535

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34787404&oldid=1978449230"